摘要
目的探讨β受体在婴幼儿血管瘤组织中的表达及意义。方法采用免疫组织化学SP法,检测40例婴幼儿血管瘤(实验组)、20例静脉畸形及10例正常皮肤(阴性对照组)标本组织中β受体的表达。结果40例婴幼儿血管瘤中仅在28例标本中见β2受体呈阳性表达,阳性表达率70%(28/40),β1受体未见表达;28例阳性标本中24例为增殖期,4例为非增殖期,婴幼儿血管瘤与静脉畸形、正常皮肤组织β2受体阳性表达比较,差异有统计学意义,β2受体在增殖期与消退期的阳性表达比较,差异有统计学意义(P〈0.05)。20例静脉畸形及10例正常皮肤组织中未见β1受体表达。结论β2受体特异表达于婴幼儿血管瘤,且高表达于增殖期。
Objective To investigate the expression and significance of beta-receptor (β-R) in infantile hemangioma. Methods The expression of β-R was detected by immunohistochemistry in infantile hemangioma(40 cases) , venous malformation ( 20 cases) and normal skin ( 10 cases). Results The positive expression rate of β2-R was 70% (28/40) in infantile hemangioma, while no expression of β2-R in venous malformation and normal skin. Among 28 cases with positive expression of β2-R, 24 cases were in proliferative phase. The positive expression of β2-R in infantile hamangioma was significantly higher than that in venous malformation and normal skin tissue. The positive expression of β2-R in the proliferative hemangioma and non-proliferative hemangioma was also significantly different( P 〈 0.05 ). Conclusions β2-R is specifically expressed in infantile hemangioma, especially in proliferative hemangioma.
出处
《中华整形外科杂志》
CAS
CSCD
北大核心
2013年第4期290-293,共4页
Chinese Journal of Plastic Surgery
关键词
Β受体
婴幼儿血管瘤
免疫组织化学
Beta-receptor
Infantile hemangioma
Immunohistochemistry